{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:09:31Z","timestamp":1776373771486,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["NARI\/SAC\/Intra\/2022-23\/2266"],"award-info":[{"award-number":["NARI\/SAC\/Intra\/2022-23\/2266"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.virol.2025.110391","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:12:08Z","timestamp":1736007128000},"page":"110391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approach"],"prefix":"10.1016","volume":"603","author":[{"given":"Shraddha Y.","family":"Gaikwad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrabhan","family":"Seniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Chandane-Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Nema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobhit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-2258","authenticated-orcid":false,"given":"Anupam","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110391_bib1","first-page":"1729","article-title":"Antitumorigenic action of nelfinavir: effects on multiple myeloma and hematologic malignancies","volume":"43","author":"Allegra","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.virol.2025.110391_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2165\/00003495-200059030-00014","article-title":"Nelfinavir: an update on its use in HIV infection","volume":"59","author":"Bardsley-Elliot","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.virol.2025.110391_bib3","article-title":"Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein","volume":"38","author":"Bhardwaj","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.virol.2025.110391_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1310\/hct0902-115","article-title":"Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: pediatric AIDS Clinical Trials Group (PACTG) Protocol 353","volume":"9","author":"Bryson","year":"2008","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.virol.2025.110391_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s40265-018-0934-2","article-title":"Darunavir\/cobicistat\/emtricitabine\/tenofovir Alafenamide: a review in HIV-1 infection","volume":"78","author":"Deeks","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.virol.2025.110391_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123504","article-title":"Targeting tachykinin peptides involved in viral infections through in silico approach: screening the unforeseen potency of serratiopeptidase","volume":"392","author":"Dhiman","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.virol.2025.110391_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcph.1331","article-title":"Pharmacokinetics of increased nelfinavir plasma concentrations in women during pregnancy and postpartum","volume":"59","author":"Eke","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.virol.2025.110391_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/978-3-030-63761-3_47","article-title":"Retrieval and investigation of data on SARS-CoV-2 and COVID-19 using bioinformatics approach","volume":"1318","author":"Fahmi","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2025.110391_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16027","article-title":"Cutting edge strategies for screening of novel anti-HIV drug candidates against HIV infection: a concise overview of cell based assays","volume":"9","author":"Gaikwad","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.virol.2025.110391_bib10","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1873-3468.14936","article-title":"A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV-1 replication in cellular models","volume":"598","author":"Gaikwad","year":"2024","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2025.110391_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2018.04.014","article-title":"Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy","volume":"138","author":"Gao","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.virol.2025.110391_bib12","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2025.110391_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2006.09.057","article-title":"EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK\/STAT1 signaling and implications for HIV-associated dementia","volume":"1123","author":"Giunta","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.virol.2025.110391_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/rej.2017.1959","article-title":"Attenuation of oxidative damage by coenzyme Q10 loaded nanoemulsion through oral route for the management of Parkinson's disease","volume":"21","author":"Gupta","year":"2018","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.virol.2025.110391_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110391_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116312","article-title":"Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan\/fucoidan nanoparticles","volume":"242","author":"Huang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.virol.2025.110391_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11101942","article-title":"Elucidation of antiviral and antioxidant potential of C-phycocyanin against HIV-1 infection through in silico and in vitro approaches","volume":"11","author":"Jadaun","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.virol.2025.110391_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12985-023-02130-y","article-title":"Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection","volume":"20","author":"Jadaun","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110391_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-023-03916-x","article-title":"Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection","volume":"23","author":"Jadaun","year":"2023","journal-title":"BMC complementary medicine and therapies"},{"key":"10.1016\/j.virol.2025.110391_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpb.2011.11.005","article-title":"Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS)","volume":"80","author":"Kang","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.virol.2025.110391_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14712598.2021.1828858","article-title":"Current status of probiotics for prevention and management of gastrointestinal cancers","volume":"21","author":"Khan","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.virol.2025.110391_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5958\/0974-360X.2021.00083.4","article-title":"Antiretroviral effect simulation from black tea (Camellia sinensis) via dual inhibitors mechanism in HIV-1 and its social perspective in Indonesia","volume":"14","author":"Kharisma","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.virol.2025.110391_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.56499\/jppres21.1009_9.4.435","article-title":"Tea catechin as antiviral agent via apoptosis agonist and triple inhibitor mechanism against HIV-1 infection: a bioinformatics approach","volume":"9","author":"Kharisma","year":"2021","journal-title":"J Pharm Pharmacogn Res"},{"key":"10.1016\/j.virol.2025.110391_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.56499\/jppres21.1174_10.1.138","article-title":"Herbal combination from Moringa oleifera Lam. and Curcuma longa L. as SARS-CoV-2 antiviral via dual inhibitor pathway: a viroinformatics approach","volume":"10","author":"Kharisma","year":"2022","journal-title":"J Pharm Pharmacogn Res"},{"key":"10.1016\/j.virol.2025.110391_bib25","article-title":"Revealing novel antiretroviral candidate from Garcinia mangostana L. Againts HIV-1 infection via reverse transcriptase inhibition: in silico study","volume":"1777\u20131783","author":"Kharisma","year":"2024","journal-title":"RJPT"},{"key":"10.1016\/j.virol.2025.110391_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.651497","article-title":"Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier","volume":"29","author":"Kim","year":"2012","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.virol.2025.110391_bib27","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1073\/pnas.85.13.4686","article-title":"Active human immunodeficiency virus protease is required for viral infectivity","volume":"85","author":"Kohl","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2025.110391_bib28","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/43\/435101","article-title":"Design Expert \u00ae supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease","volume":"27","author":"Kumar","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.virol.2025.110391_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3851\/IMP1774","article-title":"Epigallocatechin gallate inhibits the HIV reverse transcription step","volume":"21","author":"Li","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virol.2025.110391_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molliq.2015.10.027","article-title":"Nanoemulsion as a tool for improvement of Cilostazol oral bioavailability","volume":"212","author":"Mahour","year":"2015","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.virol.2025.110391_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1369757","article-title":"Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture","volume":"15","author":"McMullan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virol.2025.110391_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2452480","article-title":"Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110391_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"Montefiori","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2025.110391_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.colsurfb.2014.09.031","article-title":"Novel nelfinavir mesylate loaded d-\u03b1-tocopheryl polyethylene glycol 1000 succinate micelles for enhanced pediatric anti HIV therapy: in vitro characterization and in vivo evaluation","volume":"123","author":"Moretton","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.virol.2025.110391_bib35","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.virol.2025.110391_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10837450.2010.535825","article-title":"New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs","volume":"17","author":"Mura","year":"2012","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.virol.2025.110391_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122226","article-title":"Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infection","volume":"334","author":"Mutalik","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.virol.2025.110391_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jddst.2017.05.019","article-title":"Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability","volume":"40","author":"Nagi","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.virol.2025.110391_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425255.2.2.285","article-title":"A review of nelfinavir for the treatment of HIV infection","volume":"2","author":"Olmo","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.virol.2025.110391_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13346-014-0191-1","article-title":"Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe's design for improvement of oral bioavailability of nelfinavir mesylate","volume":"4","author":"Patel","year":"2014","journal-title":"Drug Deliv. and Transl. Res."},{"key":"10.1016\/j.virol.2025.110391_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00894-023-05569-6","article-title":"Bioprospecting phytochemicals of Rosmarinus officinalis L. for targeting SARS-CoV-2 main protease (Mpro): a computational study","volume":"29","author":"Patel","year":"2023","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.virol.2025.110391_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/AAC.40.2.292","article-title":"Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease","volume":"40","author":"Patick","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110391_bib43","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/v1031209","article-title":"Current and novel inhibitors of HIV protease","volume":"1","author":"Pokorn\u00e1","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110391_bib44","series-title":"Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice","author":"Qiu","year":"2009"},{"key":"10.1016\/j.virol.2025.110391_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24350","article-title":"Role of diosgenin extracted from Helicteres isora L in suppression of HIV-1 replication: an in vitro preclinical study","volume":"10","author":"Rakshit","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.virol.2025.110391_bib46","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1021\/acschemneuro.3c00368","article-title":"Epigallocatechin gallate: a multifaceted molecule for neurological disorders and neurotropic viral infections","volume":"14","author":"Rani","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.virol.2025.110391_bib47","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.2147\/IJN.S217898","article-title":"Conjugation of EGCG and chitosan NPs as A novel nano-drug delivery system","volume":"14","author":"Safer","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.virol.2025.110391_bib48","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/CON.0000000000000647","article-title":"Neurologic complications of human immunodeficiency virus infection","volume":"24","author":"Saylor","year":"2018","journal-title":"Continuum"},{"key":"10.1016\/j.virol.2025.110391_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.virol.2025.110391_bib50","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1016\/S2222-1808(14)60492-8","article-title":"In-silico modelling and identification of a possible inhibitor of H1N1 virus","volume":"4","author":"Seniya","year":"2014","journal-title":"Asian Pacific Journal of Tropical Disease"},{"key":"10.1016\/j.virol.2025.110391_bib51","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1109\/TCBB.2015.2415771","article-title":"In-silico studies show potent inhibition of HIV-1 reverse transcriptase activity by a herbal drug","volume":"12","author":"Seniya","year":"2015","journal-title":"IEEE ACM Trans. Comput. Biol. Bioinf"},{"key":"10.1016\/j.virol.2025.110391_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2011.04.012","article-title":"Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein","volume":"79","author":"Shanmugam","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.virol.2025.110391_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123039","article-title":"Structural insights into the lead identification of sub-type selective PDE4B inhibitors from plant bioactive molecule analogues","volume":"390","author":"Sharma","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.virol.2025.110391_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.104890","article-title":"Role of rutin nanoemulsion in ameliorating oxidative stress: pharmacokinetic and pharmacodynamics studies","volume":"228","author":"Sharma","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.virol.2025.110391_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpsychires.2018.01.015","article-title":"Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression","volume":"99","author":"Sindhu","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.virol.2025.110391_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cancers14010099","volume":"14","author":"Subeha","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.virol.2025.110391_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jsps.2015.02.021","article-title":"Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect","volume":"23","author":"Venkatesh","year":"2015","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.virol.2025.110391_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135885","article-title":"Optimizing rosemary oil nanoemulsion loaded with nelfinavir and epigallocatechin gallate: a Design Expert\u00ae endorsed approach for enhanced neuroAIDS management","author":"Verma","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virol.2025.110391_bib59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13046-018-0904-2","article-title":"Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells","volume":"37","author":"Veschi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.virol.2025.110391_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104620","article-title":"An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses","volume":"152","author":"Wani","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.virol.2025.110391_bib61","doi-asserted-by":"crossref","DOI":"10.4081\/hls.2024.12047","article-title":"Antiretroviral activity from elderberry (Sambucus nigra L.) flowers against HIV-2 infection via reverse transcriptase inhibition: a viroinformatics study","author":"Zainul","year":"2024","journal-title":"Healthc Low-resour S"},{"key":"10.1016\/j.virol.2025.110391_bib62","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/AAC.45.4.1086-1093.2001","article-title":"Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities","volume":"45","author":"Zhang","year":"2001","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T13:04:47Z","timestamp":1769951087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":62,"alternative-id":["S0042682225000030"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110391","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approach","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110391"}}